SK Biopharaceuticals set to make splash after IPO
By Chung Joo-won
SEOUL, July 1 (Yonhap) -- SK Biopharamceuticals Co. Ltd., a unit of South Korean conglomerate SK Group, will make a debut on the local bourse this week, probably emerging as the top pick by investors for its growth potential amid the coronavirus pandemic.
The initial public offering (IPO) price of SK Biopharmaceutical was set at 49,000 won (US$40.73), and the company will raise some 1 trillion won from the market debut, the largest IPO of the year so far, according to the Korea Exchange, the country's bourse operator.
The drugmaker's market cap is estimated at roughly 3.84 trillion won, but analysts put the market value of SK Biopharmaceuticals at up to 6 trillion won.
In 2019, SK Pharmaceutical's sales stood at 123.8 billion won but suffered a net loss of 91 billion won.
SK Group is the listed company's largest shareholder with a 75 percent stake. In 2011, SK Biopharmaceuticals was spun off from SK Group's life science unit.
Prior to its IPO, investors had rushed to buy SK Pharmaceuticals, chipping in 31 trillion won in deposits to buy its stocks, the largest in the country's IPO history. The previous record was 30.1 trillion won in 2014 for Cheil Industries Co., a holding company of the country's leading conglomerate Samsung Group.
In November, SK Biopharmaceuticals was the first South Korean company to independently develop an investigational anti-epileptic drug, Cenobamate, with approval from the U.S. Food and Drug Administration (FDA).
jwc@yna.co.kr
(END)
-
S. Korea expresses deep regret over Japanese PM's offering to war shrine
-
(LEAD) Yoon pledges to improve ties with Japan, offers economic aid in exchange for N.K. denuclearization
-
(LEAD) Bill Gates calls for S. Korea to play leading role in global health cooperation
-
DP warns Yoon's Liberation Day speech will give 'wrong signal' to Japan
-
(LEAD) Ex-ruling party chief files another lawsuit against leadership switch
-
(LEAD) Yoon pledges to improve ties with Japan, offers economic aid in exchange for N.K. denuclearization
-
Ex-ruling party chair takes swipe at Yoon amid legal action over leadership switch
-
(LEAD) Ex-ruling party chief files another lawsuit against leadership switch
-
Today in Korean history
-
(LEAD) DP drops party charter revision proposal
-
Supreme Court expected to decide soon whether to finalize liquidation order against Mitsubishi
-
U.S. agrees with taking 'incremental steps' to denuclearize Korean Peninsula: State Dept.
-
Clash of 2 S. Koreans on horizon in Premier League
-
(3rd LD) N. Korea rejects S. Korea's 'audacious initiative' in statement by leader's sister
-
S. Korea's new COVID-19 cases fall below 140,000; death toll hits 3-month high